Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVidendum Plc Regulatory News (VID)

Share Price Information for Videndum Plc (VID)

Share Price is delayed by 15 minutes
Get Live Data
377.50    -14.50 (-3.70%)
Bid:
375.00
Ask:
380.00
Spread: 5.00 (1.333%)
Market Cap: £157.95m
VID Live PriceLast checked at - London Stock Exchange

Intraday Videndum Plc Share Chart

2024 Half Year Post-close Statement

11 Jul 2024 07:00

RNS Number : 9471V
Videndum PLC
11 July 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO THE SAME WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

11 July 2024

Videndum plc

2024 Half Year Post-close Statement

Videndum plc ("the Group" or "the Company"), the international provider of premium branded hardware products and software solutions to the content creation market, issues a post-close statement for the half year ended 30 June 2024.

The Group's first half revenue was broadly in line with its expectations, reflecting some post-strike recovery in the cine and scripted TV market, however the recovery is taking longer than anticipated. Net debt at 30 June 2024 was c.£118 million, down from £122.4 million at 31 March 2024. 

The macroeconomic environment affecting the consumer and independent content creator segments remains challenging, and the Group has maintained its focus on controlling costs, capex and working capital tightly. The Broadcast TV segment continues to perform well, and the Group's second half performance will benefit from the Summer 2024 Olympic Games and the US Presidential election.

The Board continues to expect a recovery in the second half of FY 2024 as the cine and scripted TV market gradually recovers. Although we are seeing signs of improvement, as previously highlighted, the pace and shape of the post-strike recovery remains uncertain.

As expected, the Group has renegotiated its committed Revolving Credit Facility ("RCF") with its lending banks. The facility has been extended, reduced in quantum, and its lending covenants, particularly interest cover, relaxed - see note 1 for details. These amendments to the RCF preclude the Board from declaring a dividend until delivery of the 31 March 2025 covenant test.

Videndum's interim results for the six months ending 30 June 2024 are expected to be released in late September 2024.

 

For more information please contact:

Videndum plc

Telephone: 020 8332 4602

Stephen Bird, Group Chief Executive

Andrea Rigamonti, Group Chief Financial Officer

 

Notes to Editors:

Videndum is a leading global provider of premium branded hardware products and software solutions to the content creation market. We are organised in three Divisions: Videndum Media Solutions, Videndum Production Solutions and Videndum Creative Solutions.

Videndum's customers include broadcasters, film studios, production and rental companies, photographers, independent content creators ("ICC"), professional musicians and enterprises. Our product portfolio includes camera supports, video transmission systems and monitors, live streaming solutions, smartphone accessories, robotic camera systems, prompters, LED lighting, mobile power, carrying solutions, backgrounds, audio capture, and noise reduction equipment.

We employ around 1,600 people across the world in ten different countries. Videndum plc is listed on the London Stock Exchange, ticker: VID.

More information can be found at: https://videndum.com/

LEI number: 2138007H5DQ4X8YOCF14

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of Videndum plc is Jon Bolton, Group Company Secretary.

 

Notes

1

Lending covenants have been amended for June 2024 (leverage² to 4.25x and interest cover³ to 1.5x), September 2024 (interest cover³ to 2.25x), and December 2024 (interest cover³ to 3.0x); interest cover³ to 3.5x thereafter, and quarterly test dates to continue.

Total committed facility has been reduced by £50 million to £150 million reflecting the lower level of borrowings that the Group is operating with after the equity raise in December 2023. Net debt at 30 June 2024 was c.£118 million comprising c.£86 million borrowings net of cash and cash equivalents, and c.£32 million IFRS 16 lease liabilities.

Termination date has been extended by six months to 14 August 2026.

2

Leverage is calculated as net debt before arrangement fees and after leases of discontinued operations, divided by covenant EBITDA for the applicable 12-month period (being adjusted EBITDA, before share-based payment charges, and after interest on employee benefits, interest related net currency translation gains, and the amortisation of loan arrangement fees); see the Glossary in the Annual Report 2023 for further detail.

3

Interest cover is calculated as covenant EBITA for the applicable 12-month period (being adjusted EBITDA less depreciation of PP&E) divided by adjusted net finance expense (before interest on employee benefits and FX movements, and the amortisation of arrangement fees); see the Glossary in the Annual Report 2023 for further detail.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGMNRGKGDZM
Date   Source Headline
31st Mar 20257:00 amRNSMarch Covenant Test Waived
19th Mar 20257:00 amRNSDirectorate Change
11th Mar 20253:45 pmRNSHolding(s) in Company
5th Mar 20254:00 pmRNSHolding(s) in Company
21st Feb 20257:00 amRNSTrading Update
8th Jan 20257:00 amRNSHolding(s) in Company
7th Jan 202510:00 amRNSDirector/PDMR Shareholding
19th Dec 20241:38 pmRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSPre-Close Trading Update
11th Dec 20247:00 amRNSPre-Close Trading Update - Change of Date
22nd Nov 20242:15 pmRNSHolding(s) in Company
22nd Nov 20241:00 pmRNSNotice of Pre-Close Trading Update
20th Nov 20247:00 amRNSBlock listing Interim Review
6th Nov 20248:50 amRNSTransaction in Own Shares and cancellation
6th Nov 20248:34 amRNSShare buyback and cancellation programme
1st Nov 20249:58 amRNSTotal Voting Rights
28th Oct 20247:00 amRNSDirectorate Changes
10th Oct 20243:45 pmRNSHolding(s) in Company
8th Oct 20243:05 pmRNSHolding(s) in Company
4th Oct 20247:00 amRNSHolding(s) in Company
1st Oct 20243:40 pmRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSHolding(s) in Company
27th Sep 20243:30 pmRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNS2024 Interim Results
2nd Sep 20249:23 amRNSTotal Voting Rights
1st Aug 202412:30 pmRNSTotal Voting Rights
11th Jul 20247:00 amRNS2024 Half Year Post-close Statement
19th Jun 202411:05 amRNSResult of AGM
19th Jun 20247:00 amRNSNon-Executive Director appointment
13th Jun 202411:00 amRNSDirector/PDMR Shareholding
20th May 202411:45 amRNSBlock listing Interim Review
16th May 20245:00 pmRNSDirector/PDMR Shareholding
10th May 202410:26 amRNSChange in Director's Details
8th May 20244:15 pmRNSAnnual Report & Accounts and Notice of 2024 AGM
7th May 202411:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSDirectorate Change
23rd Apr 20247:10 amRNSDirectorate Change
23rd Apr 20247:00 amRNS2023 Full Year Results
27th Mar 20242:03 pmRNSUpdate on timing of 2023 Full Year Results
13th Mar 20242:15 pmRNSDelay to 2023 Full Year Results Date
7th Mar 20241:30 pmRNSHolding(s) in Company
23rd Feb 20244:38 pmRNSHolding(s) in Company
9th Feb 202410:46 amRNSHolding(s) in Company
26th Jan 202411:38 amRNSHolding(s) in Company
11th Jan 20244:47 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSTotal Voting Rights
12th Dec 20232:01 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSHolding(s) in Company
11th Dec 202312:27 pmRNSHolding(s) in Company
11th Dec 20238:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.